Nearly half of depression patients struggle with treatment resistance
- Nearly half of patients diagnosed with depression do not respond to standard treatment, indicating a significant gap in mental healthcare effectiveness.
- Patients with treatment-resistant depression face worse physical health and shorter lifespans compared to those who respond to treatments.
- The study found that 36.9% of patients tried four or more different antidepressants without adequate response, leading to feelings of frustration and hopelessness.
- Researchers emphasize the need for personalized and innovative approaches in treating treatment-resistant depression cases, rather than a 'one-size-fits-all' model.
24 Articles
24 Articles
New Study Could Explain Why Teenage Girls Are More Depressed Than Boys
The kynurenine pathway may explain why teenage girls are more prone to depression, with inflammation linked to more harmful brain chemicals. Depression is a mental health condition affecting approximately 280 million people worldwide. It is twice as common in women as in men, a disparity that begins to emerge during adolescence. While previous research has [...]
Nearly Half of Depression Patients Have a Treatment-Resistant Condition
A new study revealed that half of the people with depression do not respond to treatment. Something needs to be done for these individuals—and soon. According to the Mayo Clinic, “Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Also called major depressive disorder or clinical depression, it affects how you feel, think, and behave and can lead to a variety of emotional and physical problems. You ma…
New option for patients with treatment-resistant depression
AUSTIN (KXAN)- Experts estimate that treatment-resistant depression (TRD) impacts about 2.8 million Americans annually, and a groundbreaking implantable device may offer new hope. Depression affects about one in six people, and about 16 million Americans deal with depression each year. Depression can be a life-threatening condition that affects not only the individual but family and friends as well. Depression is known to be mostly treatable, bu…
Psychopharmaceuticals: 50 years of stagnation?
The 1950s and 1960s were the golden age of psychiatry. At that time, reliable options were being discovered that curbed the shadows of the mind and regulated emotional pain. Antipsychotics that blocked the reception of dopamine and antidepressants that acted on the reuptake of serotonin were chanced upon. It was a radical development that emerged from a vacuum and led to drugs that muted the voices of schizophrenia or threw a lifeline to suffere…
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage